Clinical Trial Update: Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral L-carnitine for lipid profile, anemia, and quality of life in patients with complications of hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• L-carnitine (L-carnitine)

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Complication of Hemodialysis | Phase 2 | Status: COMPLETED